← Leaderboards
Mieczyslaw Michael Michalkiewicz
West Virginia University
$1,477,514
Attributed
$1,477,514
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $227.3K · FY2006–10$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,477,514 · 2
By mechanism
P01$854,578 · 1
R01$622,936 · 1
Top collaborators
No co-investigators on record.
Most similar at West Virginia University
Same institution · by research overlap
- Chris None Baylis$7,483,914
- Matthew A Boegehold$1,020,896
- Joshua D Gross$289,434
- Lisa M Salati$3,109,604
- Ming Pei$2,474,183
Others in their field
Top investigators on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Paula Darby Lipman · Westat, Inc.$52,914,492
- Walter N Kernan · Yale University$42,197,025
- Rohit Varma · University Of Southern California$35,266,606
- Susan S Redline · Brigham And Women'S Hospital$35,248,244
- Marlene Rabinovitch · Stanford University$34,807,202
Research focus
HypertensionVasomotionProtein LocalizationReceptor ExpressionVascular ResistanceLaboratory RatVascular Smooth Muscle Nervous ControlNeuropeptide ReceptorNeuropeptide YNorepinephrineGenetically Modified AnimalsBlood PressureServicesInjection Of Therapeutic AgentLentivirus VectorProductionRattusTransgenic OrganismsNumbersGeneticBasePhysiological
Grant awards (8)
Core--Transgenic$227,255
P01 · FY2010 · HL · contact PI
Core--Transgenic$220,639
P01 · FY2009 · HL · contact PI
Core--Transgenic$209,928
P01 · FY2008 · HL · contact PI
Core--Transgenic$196,756
P01 · FY2006 · HL · contact PI
TRANSGENIC STUDY VASCULAR ROLE OF NEUROPEPTIDE Y$217,623
R01 · FY2002 · HL
TRANSGENIC STUDY VASCULAR ROLE OF NEUROPEPTIDE Y$132,357
R01 · FY2001 · HL
TRANSGENIC STUDY VASCULAR ROLE OF NEUROPEPTIDE Y$73,294
R01 · FY2001 · HL
TRANSGENIC RAT TO STUDY VASCULAR ROLE OF NEUROPEPTIDE Y$199,662
R01 · FY2000 · HL